Global Ophthalmic Implants Market 2023-2029
The global ophthalmic implants market size is projected to grow by USD 2.2 billion from 2023 to 2029, registering a CAGR of 6.1 percent, according to the latest market data. The aging population, rising life expectancy, and unfavorable changes in lifestyle, such as unhealthy eating habits and decreased exercise are likely to increase the prevalence of vision-threatening diseases in the future. The prevalence of vision-threatening diseases, such as glaucoma, cataract, and age-related macular degeneration, is likely to drive the growth of the ophthalmic implants market globally.The aging population, rising life expectancy, and unfavorable changes in lifestyle, such as unhealthy eating habits and decreased exercise are likely to increase the prevalence of vision-threatening diseases in the future. The prevalence of vision-threatening diseases, such as glaucoma, cataract, and age-related macular degeneration, is likely to drive the growth of the ophthalmic implants market globally.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global ophthalmic implants market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for ophthalmic implants can be segmented by product: intraocular lenses, glaucoma implants, corneal implants, others. The IOLs segment was the largest contributor to the global ophthalmic implants market in 2022. Ophthalmic implants market is further segmented by application: cataract surgery, glaucoma surgery, others. According to the research, the cataract surgery segment had the largest share in the global ophthalmic implants market. Based on end user, the ophthalmic implants market is segmented into: ambulatory surgery centers (ASCs), hospitals, ophthalmology clinics, others. The hospitals segment held the largest revenue share in 2022. On the basis of region, the ophthalmic implants market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Globally, North America made up the largest share of the ophthalmic implants market.
Market Segmentation
By product: intraocular lenses, glaucoma implants, corneal implants, others
By application: cataract surgery, glaucoma surgery, others
By end user: ambulatory surgery centers (ASCs), hospitals, ophthalmology clinics, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report explores the recent developments and profiles of key vendors in the Global Ophthalmic Implants Market, including 66 Vision Tech Co., Ltd., AJL Ophthalmic S.A., Alcon Inc., Bausch & Lomb Incorporated, BVI Holdings Ltd., Carl Zeiss AG, CorNeat Vision Ltd., Eyekon Medical, Inc., F. Ad. Muller Sohne GmbH & Co. KG, Glaukos Corporation, Hoya Corporation, HumanOptics AG, InnFocus, Inc. (Santen Pharmaceutical Co., Ltd.), Johnson & Johnson, Kowa Company, Ltd., LambdaVision, Inc., LensGen Inc., Medennium Inc., Morcher GmbH, Nidek Co., Ltd., Ophtec B.V., PolyActiva Pty Ltd., Rayner Intraocular Lenses Limited, SIFI SpA, STAAR Surgical AG, TEKIA, Inc., Vivani Medical, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Scope of the Report
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook